-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Maintains Buy on Oruka Therapeutics, Raises Price Target to $73

Benzinga·01/12/2026 16:31:06
Listen to the news
BTIG analyst Julian Harrison maintains Oruka Therapeutics (NASDAQ:ORKA) with a Buy and raises the price target from $63 to $73.